A detailed history of Winton Group LTD transactions in Xencor Inc stock. As of the latest transaction made, Winton Group LTD holds 44,598 shares of XNCR stock, worth $829,968. This represents 0.07% of its overall portfolio holdings.

Number of Shares
44,598
Previous 23,099 93.07%
Holding current value
$829,968
Previous $490,000 101.22%
% of portfolio
0.07%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$18.65 - $26.52 $400,956 - $570,153
21,499 Added 93.07%
44,598 $986,000
Q4 2023

Feb 12, 2024

BUY
$16.53 - $21.42 $73,294 - $94,976
4,434 Added 23.76%
23,099 $490,000
Q3 2023

Nov 13, 2023

BUY
$20.08 - $25.39 $151,162 - $191,135
7,528 Added 67.59%
18,665 $376,000
Q2 2023

Aug 14, 2023

SELL
$24.77 - $29.9 $54,122 - $65,331
-2,185 Reduced 16.4%
11,137 $278,000
Q1 2023

May 12, 2023

SELL
$25.95 - $36.95 $562,492 - $800,928
-21,676 Reduced 61.93%
13,322 $371,000
Q4 2022

Feb 14, 2023

BUY
$24.79 - $30.86 $211,830 - $263,698
8,545 Added 32.3%
34,998 $911,000
Q3 2022

Nov 10, 2022

SELL
$24.62 - $32.44 $216,237 - $284,920
-8,783 Reduced 24.93%
26,453 $687,000
Q2 2022

Aug 10, 2022

BUY
$19.74 - $29.01 $235,083 - $345,480
11,909 Added 51.05%
35,236 $964,000
Q1 2022

May 11, 2022

BUY
$26.68 - $41.63 $397,291 - $619,912
14,891 Added 176.52%
23,327 $622,000
Q4 2021

Feb 10, 2022

SELL
$33.67 - $43.44 $783,197 - $1.01 Million
-23,261 Reduced 73.39%
8,436 $338,000
Q3 2021

Oct 28, 2021

SELL
$30.65 - $35.68 $12,076 - $14,057
-394 Reduced 1.23%
31,697 $1.04 Million
Q2 2021

Aug 10, 2021

SELL
$34.33 - $44.68 $29,043 - $37,799
-846 Reduced 2.57%
32,091 $1.11 Million
Q1 2021

Jul 21, 2021

SELL
$40.81 - $53.88 $191,154 - $252,373
-4,684 Reduced 12.45%
32,937 $1.42 Million
Q4 2020

Feb 12, 2021

SELL
$36.63 - $47.63 $3.39 Million - $4.41 Million
-92,496 Reduced 71.09%
37,621 $1.64 Million
Q3 2020

Oct 30, 2020

SELL
$30.09 - $43.02 $1.59 Million - $2.28 Million
-52,999 Reduced 28.94%
130,117 $5.05 Million
Q2 2020

Aug 05, 2020

SELL
$27.76 - $33.42 $862,059 - $1.04 Million
-31,054 Reduced 14.5%
183,116 $5.93 Million
Q1 2020

May 11, 2020

SELL
$20.69 - $37.79 $1.06 Million - $1.93 Million
-51,134 Reduced 19.27%
214,170 $6.4 Million
Q4 2019

Feb 13, 2020

BUY
$32.75 - $41.43 $7.86 Million - $9.95 Million
240,151 Added 954.76%
265,304 $9.12 Million
Q3 2019

Nov 08, 2019

BUY
$33.73 - $46.27 $848,410 - $1.16 Million
25,153 New
25,153 $848,000
Q2 2019

Jul 08, 2019

SELL
$29.6 - $40.93 $246,656 - $341,069
-8,333 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$27.85 - $38.09 $232,074 - $317,403
8,333 New
8,333 $259,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.11B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.